For decades, an unassuming government vaccine safety surveillance system has done its job, quickly flagging possible side effects and allowing scientists and regulators to investigate further. But for ...
Clinical trials utilize multiple methods of tracking, categorizing, and assessing any side effects at each trial stage. A negative side effect during clinical trials, whether expected as a potential ...
Since its creation in 1990, the U.S. Centers for Disease Control and Prevention’s (CDC) Vaccine Adverse Event Reporting System (VAERS) has provided publicly available data on any adverse reactions ...
Adverse event (AE) reporting is a critical component in the conduct and evaluation of clinical trials. Methods of AE reporting have evolved with the complexity of cancer treatments. Reporting the ...
A multidisciplinary panel of medical oncology, dermatology, gastroenterology, rheumatology, pulmonology, endocrinology, neurology, hematology, emergency medicine ...
Immunotherapy enhances a patient’s immune system to fight disease and has recently been a source of promising new cancer treatments. Among the many immunotherapeutic strategies, immune checkpoint ...
Please provide your email address to receive an email when new articles are posted on . The FDA Adverse Event Reporting System will now host daily publications, instead of quarterly. The agency’s goal ...
The choice of the dose of an anticancer drug is established in first-in-human, dose-escalation, phase 1 clinical trials involving patients with cancer for whom standard-of-care treatments are often no ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results